Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | PRKCG | P05129 | 5/20 | 0.32 |
| ▸ | PRKCB | P05771 | 5/20 | 0.32 |
| ▸ | PRKCH | P24723 | 5/20 | 0.32 |
| ▸ | PRKCE | Q02156 | 5/20 | 0.32 |
| ▸ | PRKCQ | Q04759 | 5/20 | 0.32 |
| ▸ | PRKCD | Q05655 | 5/20 | 0.32 |
| ▸ | PRKCA | P17252 | 4/20 | 0.32 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.31 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.30 |
| ▸ | PRKCI | P41743 | 2/20 | 0.30 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.30 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2935148 | 0.77 | PTPN1 (0.43) | PPARAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3926402 | 0.66 | PTPN1 (0.50) | PPARAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3220267 | 0.65 | PTPN1 (0.48) | PPARAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL3923934 | 0.63 | PTPN1 (0.53) | — | |
| SCHEMBL27758456 | 0.60 | PPARA (0.42) | PPARAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL22147320 | 0.59 | NPC1 (0.59) | PPARAKAT8 | |
| SCHEMBL3919036 | 0.59 | PTPN1 (0.56) | — | |
| SCHEMBL2936209 | 0.59 | PTPN1 (0.50) | PPARAPRKCGPRKCBPRKCHPRKCE | |
| SCHEMBL2459556 | 0.58 | LPL (0.54) | PPARA | |
| SCHEMBL9660323 | 0.58 | PPARA (0.64) | PPARAKAT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2227245-A2 | COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS | Novartis AG (CH) | 2010-09-15 | — | — | EP | disclosed |
| WO-2009068689-A2 | COMBINATION OF PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND HUMAN GROWTH HORMONE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS | NOVARTIS AG (CH) | 2009-06-04 | — | — | WO | disclosed |